Search research articles
Contact Us
Filters
Showing results (71-80 of 140) with videos related to
Page
of 14
Sort By:
International Journal of Oncology
|
November 26, 2014
Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
Chia-Jung Hsieh, Po-Lin Kuo, Ming-Feng Hou, et al.
Oncology Reports
|
December 19, 2017
Investigation of the role of tumor necrosis factor-like weak inducer of apoptosis in non-small cell lung cancer
Wei-An Chang, Meng-Chi Yen, Jen-Yu Hung, et al.
Oncotarget
|
December 30, 2017
Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis
Ya-Ling Hsu, Jen-Yu Hung, Yen-Lung Lee, et al.
The Kaohsiung Journal of Medical Sciences
|
July 20, 2010
Outcome of physical therapy intervention on ventilator weaning and functional status
Pei-Hsuan Yang, Chuan-Sheng Wang, Yen-Ching Wang, et al.
Journal of Clinical Medicine
|
February 16, 2019
CHADS₂, CHA₂DS₂ASc, and New ABCD Scores Predict the Risk of Peripheral Arterial Disease in Patients with Sleep Apnea
Kuan-Li Wu, Chia-Yu Kuo, Yu-Chen Tsai, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
|
October 11, 2021
The association between cataract and sleep apnea: a nationwide population-based cohort study
Pei-Kang Liu, Yo-Chen Chang, Nan-Kai Wang, et al.
Oncotargets and Therapy
|
April 7, 2016
Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment
Chih-Jen Yang, Ming-Ju Tsai, Jen-Yu Hung, et al.
International Journal of Cancer
|
December 19, 2013
Synergistic effect of lung tumor-associated dendritic cell-derived HB-EGF and CXCL5 on cancer progression
Po-Lin Kuo, Ming-Shyan Huang, Jen-Yu Hung, et al.
Oncology Reports
|
September 24, 2015
Benzyl butyl phthalate increases the chemoresistance to doxorubicin/cyclophosphamide by increasing breast cancer-associated dendritic cell-derived CXCL1/GROα and S100A8/A9
Ya-Ling Hsu, Jen-Yu Hung, Eing-Mei Tsai, et al.
BMC Pharmacology & Toxicology
|
December 15, 2017
The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 21 mutations
Chih-Jen Yang, Ming-Ju Tsai, Jen-Yu Hung, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 140) with videos related to
Sort By:
Page
of 14
International Journal of Oncology
|
November 26, 2014
Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
Chia-Jung Hsieh, Po-Lin Kuo, Ming-Feng Hou, et al.
Oncology Reports
|
December 19, 2017
Investigation of the role of tumor necrosis factor-like weak inducer of apoptosis in non-small cell lung cancer
Wei-An Chang, Meng-Chi Yen, Jen-Yu Hung, et al.
Oncotarget
|
December 30, 2017
Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis
Ya-Ling Hsu, Jen-Yu Hung, Yen-Lung Lee, et al.
The Kaohsiung Journal of Medical Sciences
|
July 20, 2010
Outcome of physical therapy intervention on ventilator weaning and functional status
Pei-Hsuan Yang, Chuan-Sheng Wang, Yen-Ching Wang, et al.
Journal of Clinical Medicine
|
February 16, 2019
CHADS₂, CHA₂DS₂ASc, and New ABCD Scores Predict the Risk of Peripheral Arterial Disease in Patients with Sleep Apnea
Kuan-Li Wu, Chia-Yu Kuo, Yu-Chen Tsai, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
|
October 11, 2021
The association between cataract and sleep apnea: a nationwide population-based cohort study
Pei-Kang Liu, Yo-Chen Chang, Nan-Kai Wang, et al.
Oncotargets and Therapy
|
April 7, 2016
Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment
Chih-Jen Yang, Ming-Ju Tsai, Jen-Yu Hung, et al.
International Journal of Cancer
|
December 19, 2013
Synergistic effect of lung tumor-associated dendritic cell-derived HB-EGF and CXCL5 on cancer progression
Po-Lin Kuo, Ming-Shyan Huang, Jen-Yu Hung, et al.
Oncology Reports
|
September 24, 2015
Benzyl butyl phthalate increases the chemoresistance to doxorubicin/cyclophosphamide by increasing breast cancer-associated dendritic cell-derived CXCL1/GROα and S100A8/A9
Ya-Ling Hsu, Jen-Yu Hung, Eing-Mei Tsai, et al.
BMC Pharmacology & Toxicology
|
December 15, 2017
The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 21 mutations
Chih-Jen Yang, Ming-Ju Tsai, Jen-Yu Hung, et al.
Page
of 14